rss
J Neurol Neurosurg Psychiatry 75:1045-1047 doi:10.1136/jnnp.2002.007724
  • Short report

The effect of immunomodulatory treatment on multiple sclerosis fatigue

Table 1

 Proportion of patients who improved by more than 1 SD

All patients (n = 218) RRMS only (n = 196)
Proportions compared using χ2 tests.
FIS, fatigue impact scale; GA, glatiramer acetate; IFN, β interferon; RRMS, relapsing-remitting multiple sclerosis.
Total FIS
GA 24.8 25.2
IFN 12.9 13.0
p = 0.033 p = 0.046
Physical subscale
GA 28.6 29.1
IFN 14.1 14.5
p = 0.013 p = 0.022
Cognitive subscale
GA 21.1 20.5
IFN 10.6 11.6
p = 0.045 p = 0.117
Social subscale
GA 18.9 19.7
IFN 14.1 15.9
p = 0.369 p = 0.518

This Article

Latest from Practical Neurology

Latest from Practical Neurology

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • BMJ Careers - Latest Neurology and Neurosurgery jobs

    Latest neurology and neurosurgery jobs